IL134050A0 - A pharmaceutical composition active in reducing production of mcp-1 protein - Google Patents
A pharmaceutical composition active in reducing production of mcp-1 proteinInfo
- Publication number
- IL134050A0 IL134050A0 IL13405098A IL13405098A IL134050A0 IL 134050 A0 IL134050 A0 IL 134050A0 IL 13405098 A IL13405098 A IL 13405098A IL 13405098 A IL13405098 A IL 13405098A IL 134050 A0 IL134050 A0 IL 134050A0
- Authority
- IL
- Israel
- Prior art keywords
- mcp
- protein
- pharmaceutical composition
- reducing production
- composition active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001788A IT1293794B1 (it) | 1997-07-28 | 1997-07-28 | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
PCT/EP1998/004925 WO1999004791A1 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134050A0 true IL134050A0 (en) | 2001-04-30 |
Family
ID=11377641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13405098A IL134050A0 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Country Status (15)
Country | Link |
---|---|
US (1) | US6191158B1 (ko) |
EP (1) | EP0999836A1 (ko) |
JP (1) | JP2001510802A (ko) |
KR (1) | KR20010022333A (ko) |
CN (1) | CN1265592A (ko) |
AU (1) | AU9160298A (ko) |
BG (1) | BG104162A (ko) |
CA (1) | CA2298507A1 (ko) |
EA (1) | EA200000168A1 (ko) |
HU (1) | HUP0004936A3 (ko) |
IL (1) | IL134050A0 (ko) |
IT (1) | IT1293794B1 (ko) |
SK (1) | SK1332000A3 (ko) |
TR (1) | TR200000244T2 (ko) |
WO (1) | WO1999004791A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20062254A1 (it) | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3970194A (en) * | 1975-01-08 | 1976-07-20 | Philip Morris Incorporated | Razor blade cartridge and display article |
IT1147079B (it) * | 1980-05-30 | 1986-11-19 | Sigma Tau Ind Farmacuetiche Ri | Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono |
IT1131779B (it) * | 1980-07-29 | 1986-06-25 | Acraf | Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione |
IT1189052B (it) * | 1981-11-27 | 1988-01-28 | Acraf | Trattamento della cataratta |
IT1197805B (it) * | 1986-08-01 | 1988-12-06 | Acraf | Metodo per il tratamento di lenti a contatto |
-
1997
- 1997-07-28 IT IT97MI001788A patent/IT1293794B1/it active IP Right Grant
-
1998
- 1998-07-22 TR TR2000/00244T patent/TR200000244T2/xx unknown
- 1998-07-22 JP JP2000503846A patent/JP2001510802A/ja active Pending
- 1998-07-22 CA CA002298507A patent/CA2298507A1/en not_active Abandoned
- 1998-07-22 SK SK133-2000A patent/SK1332000A3/sk unknown
- 1998-07-22 IL IL13405098A patent/IL134050A0/xx unknown
- 1998-07-22 CN CN98807694A patent/CN1265592A/zh active Pending
- 1998-07-22 EA EA200000168A patent/EA200000168A1/ru unknown
- 1998-07-22 EP EP98943863A patent/EP0999836A1/en not_active Withdrawn
- 1998-07-22 AU AU91602/98A patent/AU9160298A/en not_active Abandoned
- 1998-07-22 KR KR1020007000912A patent/KR20010022333A/ko not_active Application Discontinuation
- 1998-07-22 US US09/463,665 patent/US6191158B1/en not_active Expired - Fee Related
- 1998-07-22 HU HU0004936A patent/HUP0004936A3/hu unknown
- 1998-07-22 WO PCT/EP1998/004925 patent/WO1999004791A1/en not_active Application Discontinuation
-
2000
- 2000-02-17 BG BG104162A patent/BG104162A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010022333A (ko) | 2001-03-15 |
IT1293794B1 (it) | 1999-03-10 |
EP0999836A1 (en) | 2000-05-17 |
SK1332000A3 (en) | 2000-12-11 |
EA200000168A1 (ru) | 2000-08-28 |
HUP0004936A2 (hu) | 2001-11-28 |
HUP0004936A3 (en) | 2002-01-28 |
JP2001510802A (ja) | 2001-08-07 |
WO1999004791A1 (en) | 1999-02-04 |
US6191158B1 (en) | 2001-02-20 |
CA2298507A1 (en) | 1999-02-04 |
ITMI971788A1 (it) | 1999-01-28 |
BG104162A (en) | 2000-12-29 |
TR200000244T2 (tr) | 2000-09-21 |
AU9160298A (en) | 1999-02-16 |
CN1265592A (zh) | 2000-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103616A3 (en) | Therapeutically active proteins in plants | |
HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
ZA982533B (en) | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | |
HUP9601698A2 (hu) | Cukorbetegség elleni (antidiabetikus) hatású gyógyászati készítmény | |
HK1061841A1 (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | |
HU9502918D0 (en) | Pharmaceutical composition of antihypertriglyceridemic activity | |
ZA986636B (en) | A pharmaceutical composition active in reducing production of MCP-1 protein | |
ZA984266B (en) | Pharmaceutical composition and process of preparation | |
IL138137A (en) | Cholenic acid amides and pharmaceutical compositions thereof | |
HUP0003189A2 (en) | Pharmaceutical composition comprising fexofenadine and its derivatives | |
ZA983239B (en) | Stable active human ob protein compositions and methods | |
HU9802716D0 (en) | Pharmaceutical composition of analgesic activity | |
IL134050A0 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
PL337807A1 (en) | Sertralin dosage formulation in the form of a gelatine-encapsulated solution | |
AU5337198A (en) | Production of biologically active polypeptides | |
ZA9811105B (en) | Cosmetic and pharmaceutical composition | |
ZA9810846B (en) | An active hedgehog-protein-mutant a process for its preparation and its use for pharmaceutical purposes | |
HU9702369D0 (en) | Pharmaceutical composition of natural active components | |
GB9711697D0 (en) | Biologically and therapeutically active agents | |
GB9915380D0 (en) | Biologically and therapeutically active agents | |
GB9814238D0 (en) | Biologically and therapeutically active agents | |
GB9720963D0 (en) | Pharmaceutical compositions and method of production | |
GB9409478D0 (en) | Biologically and therapeutically active agents | |
GB9408684D0 (en) | Biologically and therapeutically active agents |